India
PopVax CEO on personalised cancer vaccines: ‘Experimental option, not established cure’
The Hyderabad-based startup’s new RNA Foundry will design custom tumour-targeting vaccines, but the tech remains strictly experimental. Founder and CEO Soham Sankaran explains how the process works and talks about the future of oncology care
03 Nov 2026 · 360 News Admin

360 News
The Hyderabad-based startup’s new RNA Foundry will design custom tumour-targeting vaccines, but the tech remains strictly experimental. Founder and CEO Soham Sankaran explains how the process works and talks about the future of oncology care

